NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials

NCT05301907

CompletedN/A

Sponsor: Novartis Pharmaceuticals

Conditions: Multiple Sclerosis

Countries: Switzerland

Survey to be completed independently by HCPs (neurologists treating patients with MS and MS specialist nurses) and patients/caregivers.

Eligibility overview

Sex: ALL

Age: 18 Years to 100 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

Physicians were considered eligible for the survey if they meet the following screening criteria:

* Care for relapsing MS (RMS) patients
* Personally prescribed disease modifying therapies to MS patients, and;
* Have prescribed Mayzent (siponimod) in at least 1 SPMS patient.

Nurses were considered eligible for the survey if they:

* Provide supportive care for RMS patients
* Have initiated and/or managed the use of Mayzent (siponimod) in at least 1 SPMS patient.

Patient inclusion criteria include:

\- Had initiated onto Mayzent (siponimod) to treat their MS since reimbursement

Exclusion Criteria:

\-

Locations (1)

Basel, Switzerland